Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa.
about
Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IVCorrelation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa.Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.Pseudomonas aeruginosa: resistance to the maxApplication of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy.Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype.Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosaThe role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa.Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.Characterization of mutations in DNA gyrase and topoisomerase IV Involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro.Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis.Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium.Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam.Quinolone-resistant clinical strains of Pseudomonas aeruginosa isolated from University Hospital in Tunisia.Antimicrobial and Antibiofilm Activity of Synergistic Combinations of a Commercially Available Small Compound Library With Colistin Against
P2860
Q28492734-D89EAA1E-86AD-449B-9DC2-8FB03DE06ECAQ33807598-EB34301F-0114-4617-BFE6-0151A972F001Q33975861-7CAB66F5-AA40-44C9-B64A-6F6F4753BA5FQ33982709-02BF4467-D290-4BBC-A501-7A441FE3A4F5Q34384649-A52DFCDE-7B8C-4EE2-B406-E1A88650AE39Q35084559-1F804215-7D40-4020-A051-34ED7DE197BAQ35140423-427622DC-4E4F-4555-B8F9-964E86CC96C5Q37306380-73A8B675-38B2-46BC-8D3D-43B76827F53DQ37348842-4A6E3535-0704-4AAD-A25A-C7F9D068EDFBQ39310402-D1368435-2763-4746-95A1-52D8F7B433DEQ39469894-3653C460-2B27-4BBC-9DD7-BD8ED2FCAD9DQ39470847-43414AC0-8764-4C5C-B885-4231CC7C2A85Q39475894-A9E26FF4-DFD4-4430-8E63-3F04A4DB4B8EQ39559460-85C1B74D-D5F5-404A-9882-98EE72F172FAQ39651195-C6BA88D1-3834-4371-B481-4AD5ACC2190FQ39651895-C89746C5-891E-4BBA-AA83-EAA546C2F3DEQ39755440-4250C5EE-A55C-451C-B7BD-BE40E66C8A5BQ41454301-31CA083B-FF23-4BA6-BBF0-141BF4D8DB94Q43234730-CE484517-6B0E-4885-A442-D39C8D580116Q53702253-C42B41AB-BF1B-4E4F-9D43-2B25FCDB3E12Q53716911-0261FC21-1832-4E3B-BB27-35B410BBAB0BQ58556379-F43BAE4D-7330-4A8F-BC48-9461BB23E5A3
P2860
Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Mutations in the gyrA and parC ...... tes of Pseudomonas aeruginosa.
@en
Mutations in the gyrA and parC ...... tes of Pseudomonas aeruginosa.
@nl
type
label
Mutations in the gyrA and parC ...... tes of Pseudomonas aeruginosa.
@en
Mutations in the gyrA and parC ...... tes of Pseudomonas aeruginosa.
@nl
prefLabel
Mutations in the gyrA and parC ...... tes of Pseudomonas aeruginosa.
@en
Mutations in the gyrA and parC ...... tes of Pseudomonas aeruginosa.
@nl
P2093
P2860
P356
P1476
Mutations in the gyrA and parC ...... ates of Pseudomonas aeruginosa
@en
P2093
Kawamura T
P2860
P304
P356
10.1128/AAC.41.10.2289
P407
P577
1997-10-01T00:00:00Z